PK Study of Dapagliflozin in Pediatric Subjects With T2DM
This study is currently recruiting participants.
Verified October 2012 by Bristol-Myers Squibb
Sponsor:
Bristol-Myers Squibb
Collaborators:
AstraZeneca
Parexel
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT01525238
First received: January 31, 2012
Last updated: October 5, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |